Product Information
MAPAP COLD FORMULA CAPLET is a generic product labeled by Major Pharmaceuticals, priced at $0.0958 per EA under NDC 00904578624. Its NADAC has been published 509 times since Nov 28, 2013.
Strength
325; 10; 5 mg/1; mg/1; mg/1
Manufacturer
Major PharmaceuticalsNDC
00904578624
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Approval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
7/15/2005
Pharmacological Classes
Price Statistics
The NADAC for MAPAP COLD FORMULA CAPLET has been published 509 times since Nov 28, 2013, and over the history we have for it it has risen 31.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0958 per EA |
|---|---|
| All-time high | $0.0985 (Oct 16, 2024) |
| All-time low | $0.0654 (Jul 19, 2017) |
| 52-week high | $0.0974 |
| 52-week low | $0.0903 |
| Median price | $0.0906 |
| Average price | $0.0888 |
| Largest weekly change | +24.3% (Mar 19, 2014) |
| Weeks tracked | 509 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MAPAP COLD FORMULA CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for MAPAP COLD FORMULA CAPLET, manufactured by Major Pharmaceuticals, is $0.0958 per EA (NDC 00904578624), effective Jun 24, 2026.
How has the price of MAPAP COLD FORMULA CAPLET changed over time?
Over the history we have for it, the NADAC for MAPAP COLD FORMULA CAPLET has risen 31.5%. It has been tracked across 509 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MAPAP COLD FORMULA CAPLET?
Since Nov 28, 2013, the NADAC for MAPAP COLD FORMULA CAPLET has ranged from a low of $0.0654 (Jul 19, 2017) to a high of $0.0985 (Oct 16, 2024), with a median of $0.0906 per EA.
Are there cheaper alternatives to MAPAP COLD FORMULA CAPLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as MAPAP COLD FORMULA CAPLET, but none are currently priced below it.
Who manufactures MAPAP COLD FORMULA CAPLET?
MAPAP COLD FORMULA CAPLET (NDC 00904578624) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification